תראקאפ 131

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Ingredientes activos:

SODIUM IODIDE (131 I)

Disponible desde:

ELDAN ELECTRONIC INSTRUMENTS CO LTD, ISRAEL

Código ATC:

V09FX03

formulario farmacéutico:

קפסולה קשיחה

Composición:

SODIUM IODIDE (131 I) 37 - 5550 MBQ

Vía de administración:

פומי

tipo de receta:

מרשם נדרש

Fabricado por:

GE HEALTHCARE BUCHLER GmbH & Co. KG

Grupo terapéutico:

SODIUM IODIDE (131I)

Área terapéutica:

SODIUM IODIDE (131I)

indicaciones terapéuticas:

Theracap 131 is a radioiodine thyroid therapy indicated for: 1. Treatment of Graves' disease, as well as focal or disseminated autonomies of the thyroid.2.Treatment of papillary and follicular thyroid carcinomas including metastases. - Whole-body-scintigraphy for monitoring papillary or follicular thyroid carcinoma. Sodium iodide 131 therapy is often combined with surgical intervention and with antithyroid medications.

Fecha de autorización:

2015-09-30